Abstract
AbstractThe overexpression of genes frequently arises inNakaseomyces(formerlyCandida)glabratavia gain-of-function mutations, gene duplication or aneuploidies, with important consequences on pathogenesis traits and antifungal drug resistance. This highlights the need to develop specific genetic tools to mimic and study genetic amplification in this important fungal pathogen. Here, we report the development, validation, and applications of the first CRISPR activation (CRISPRa) system inN. glabratafor targeted genetic overexpression. Using this system, we demonstrate the ability of CRISPRa to drive high levels of gene expression inN. glabrata, and further assess optimal guide RNA targeting for robust overexpression. We demonstrate the applications of CRISPRa to overexpress genes involved in fungal pathogenesis and drug resistance, and detect corresponding phenotypic alterations in these key traits, including the characterization of novel phenotypes. Finally, we capture strain variation using our CRISPRa system in two commonly usedN. glabratagenetic backgrounds. Together, this tool will expand our capacity for functional genetic overexpression in this pathogen, with numerous possibilities for future applications.
Publisher
Cold Spring Harbor Laboratory
Reference81 articles.
1. 2022. WHO fungal priority pathogens list to guide research, development and public health action. World Health Organization. https://www.who.int/publications/i/item/9789240060241. Retrieved 28 October 2022.
2. Invasive Candidiasis
3. Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
4. Candida glabrata: a review of its features and resistance
5. Fluconazole resistance in Candida glabrata